Government-backed lending increase

RNS Number : 6064L
Manx Financial Group PLC
14 January 2021
 

FOR IMMEDIATE RELEASE  14 January 2021

 

 

Manx Financial Group PLC (the "Group")

Government-backed lending increase

 

On 21st August 2020, Manx Financial Group PLC (LSE: MFX), the financial services group which includes Conister Bank Limited ("Conister") and Conister Finance & Leasing Ltd ("CFL"), announced details of its significant Government approved appointments to provide Government-backed funding to SMEs both in the Isle of Man and the UK.  This included a Disruption Loan Guarantee Agreement and Working Capital Loan Agreement in the Isle of Man and the British Bank Loan Scheme and the Coronavirus Business Interruption Loan Scheme ("CBILS") in the UK.

 

The Group, through CFL, is now pleased to announce that CFL has received approval for an increase in its lending allocation for CBILS to £15 million.  The CBILS have an 80% indemnification for any loss and are guaranteed by the UK Government.

 

Douglas Grant, the Group's Finance Director, commented:

 

"I am extremely pleased that CFL has been selected to provide additional Government-backed funding to assist SMEs as it is clear that lenders such as ourselves continue to be recognised as a vital component in keeping the SME sector alive."


This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014 on market abuse. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

Manx Financial Group PLC

Denham Eke, Chief Executive

Tel +44 (0)1624 694694

Beaumont Cornish Limited

Roland Cornish/James Biddle

Tel +44 (0) 20 7628 3396

Greentarget Limited

Dafina Grapci-Penney

Tel +44 (0) 203 963 1887

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVRLTIVLIL
UK 100

Latest directors dealings